UPDATE: Pfizer Posts Upbeat Q2 Results, Shares Gain

Loading...
Loading...
Pfizer
PFE
reported stronger-than-expected second-quarter results and cut its revenue forecast for the year. Pfizer now expects revenue of $48.7 billion to $50.7 billion, versus its earlier forecast of $49.2 billion to $51.2 billion. The New York-based company posted its quarterly earnings of $2.91 billion, or $0.45 per share, versus $14.1 billion, or $1.98 per share, in the year-ago quarter. Excluding special items, the company's earnings rose to $0.58 per share versus $0.56 per share. Its revenue slipped 1.5% to $12.77 billion. However, analysts were expecting earnings of $0.57 per share on revenue of $12.47 billion. Pfizer's research and development spending increased 13% to $1.71 billion. Pfizer's revenue in global innovative pharmaceutical fell around 5%, while revenue in global established pharmaceutical declined about 6%. Revenue in the global vaccines unit rose 13%, while revenue in consumer health care units surged 14%. Revenue in global oncology unit jumped 16%. Frank D'Amelio, Chief Financial Officer, said, “Overall, I am pleased with our second-quarter 2014 financial results despite the continued negative impact from product losses of exclusivity and the termination of certain co-promotion collaborations.” Pfizer shares gained 1.26% to $30.48 in pre-market trading.
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsGuidanceprofit
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...